P Schöffski Selected Research

P Schöffski Research Topics

Disease

25	Neoplasms (Cancer) 01/2023 - 11/2003
13	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 01/2006
9	Renal Cell Carcinoma (Grawitz Tumor) 11/2015 - 08/2006
8	Fatigue 01/2018 - 01/2000
5	Disease Progression 01/2023 - 04/2002
5	Neoplasm Metastasis (Metastasis) 11/2015 - 04/2001
5	Colorectal Neoplasms (Colorectal Cancer) 04/2008 - 02/2002
4	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 11/2003 - 04/2002
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2023 - 10/2010
3	Nausea 01/2018 - 04/2008
3	Breast Neoplasms (Breast Cancer) 01/2018 - 05/2011
3	Leiomyosarcoma 10/2013 - 04/2007
3	Testicular Neoplasms (Testicular Cancer) 11/2003 - 04/2002
2	Clear Cell Sarcoma 01/2019 - 12/2017
2	Hypertension (High Blood Pressure) 01/2017 - 11/2015
2	Melanoma (Melanoma, Malignant) 06/2011 - 01/2005
2	Diarrhea 04/2008 - 03/2006
2	Neutropenia 01/2006 - 04/2002
2	Liver Diseases (Liver Disease) 03/2004 - 10/2001
2	Xerostomia 06/2000 - 01/2000
1	Liposarcoma 04/2020
1	Alveolar Soft Part Sarcoma 01/2018
1	Clinical Deterioration 01/2018
1	Vomiting 01/2018
1	Thyroid Neoplasms (Thyroid Cancer) 11/2017
1	medullary Thyroid cancer 11/2017
1	Syncope (Fainting) 01/2017
1	Edema (Dropsy) 01/2017
1	Kaposi Sarcoma (Kaposi's Sarcoma) 04/2015
1	Infections 04/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2015
1	Carcinoma (Carcinomatosis) 02/2015
1	Glioma (Gliomas) 02/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2015
1	Synovial Sarcoma (Synovioma) 10/2013
1	Rhabdomyosarcoma 10/2013
1	Osteonecrosis (Kienbock's Disease) 11/2012

Drug/Important Bio-Agent (IBA)

7	Sunitinib (Sutent)FDA Link 06/2015 - 08/2008
4	Imatinib Mesylate (Gleevec)FDA Link 01/2023 - 08/2008
4	pazopanib FDA Link 01/2018 - 11/2015
4	TrabectedinIBA 01/2018 - 01/2006
4	Tyrosine Kinase InhibitorsIBA 07/2016 - 08/2006
4	Fluorouracil (Carac)FDA LinkGeneric 06/2013 - 04/2001
4	Cisplatin (Platino)FDA LinkGeneric 01/2011 - 12/2000
3	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 04/2002
3	CrizotinibIBA 01/2019 - 12/2017
3	Ifosfamide FDA LinkGeneric 01/2018 - 11/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2011
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2015 - 01/2011
3	Viscum ribosome inactivating proteinIBA 02/2015 - 12/2004
3	Transaminases (Aminotransferases)IBA 12/2011 - 12/2004
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2008 - 04/2001
2	Phosphotransferases (Kinase)IBA 11/2020 - 01/2015
2	Monoclonal AntibodiesIBA 01/2017 - 10/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2015 - 11/2015
2	Biomarkers (Surrogate Marker)IBA 11/2015 - 01/2015
2	Everolimus FDA Link 04/2015 - 10/2010
2	Docetaxel (Taxotere)FDA Link 06/2013 - 12/2000
2	Cytotoxins (Cytolysins)IBA 09/2012 - 04/2001
2	Alkaline PhosphataseIBA 12/2011 - 12/2004
2	Topoisomerase I InhibitorsIBA 04/2007 - 04/2002
2	Leucovorin (Folinic Acid)FDA Link 03/2006 - 10/2003
2	Irinotecan (Camptosar)FDA LinkGeneric 03/2006 - 04/2001
2	mistletoe lectin IIBA 07/2005 - 12/2004
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2002 - 10/2001
2	Bendamustine Hydrochloride FDA Link 06/2000 - 01/2000
1	avapritinibIBA 01/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	regorafenibIBA 01/2023
1	Circulating Tumor DNAIBA 01/2023
1	TropomyosinIBA 11/2020
1	tyrosine receptor (receptor, tyrosine)IBA 11/2020
1	BI-907828IBA 04/2020
1	Proteins (Proteins, Gene)FDA Link 04/2020
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	cabozantinibIBA 11/2017
1	olaratumabIBA 01/2017
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2015
1	Terbinafine (Lamisil)FDA LinkGeneric 04/2015
1	danusertibIBA 03/2015
1	Aurora KinasesIBA 03/2015
1	liposomal doxorubicin (Doxil)FDA Link 02/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2015
1	BI 6727IBA 01/2015
1	Immunoglobulin G (IgG)IBA 10/2013
1	cixutumumabIBA 10/2013
1	Immunoglobulins (Immunoglobulin)IBA 10/2013
1	MicroRNAs (MicroRNA)IBA 09/2013
1	Epirubicin (Ellence)FDA LinkGeneric 06/2013
1	AfatinibIBA 06/2013
1	multidrug resistance-associated protein 1IBA 06/2013
1	Sorafenib (BAY 43-9006)FDA Link 11/2012
1	Diphosphonates (Bisphosphonates)IBA 11/2012

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 01/2018 - 10/2001
9	Therapeutics 11/2020 - 11/2002
2	Adjuvant Chemotherapy 01/2018 - 06/2013
2	Salvage Therapy 02/2013 - 04/2003
2	Intravenous Infusions 12/2011 - 04/2004
1	Kidney Transplantation 04/2015
1	Radiotherapy 02/2015